Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
The goal is to better support drug developers as programs move from laboratory research into clinical trials
To boost compostable packaging, resin innovation, and supply chain speed
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
Subscribe To Our Newsletter & Stay Updated